K807-4500 Screening compound: 1-(4-{4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl}-3-nitrophenyl)-3-methylpyrrolidine-2,5-dione

K807-4500 Screening compound: 1-(4-{4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl}-3-nitrophenyl)-3-methylpyrrolidine-2,5-dione
K807-4500 Screening compound: 1-(4-{4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl}-3-nitrophenyl)-3-methylpyrrolidine-2,5-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound K807-4500
1-(4-{4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl}-3-nitrophenyl)-3-methylpyrrolidine-2,5-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K807-4500

Molecular Formula

C23H21ClF3N3O5 (C23 H21 ClF3 N3 O5)

Compound Name

1-(4-{4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl}-3-nitrophenyl)-3-methylpyrrolidine-2,5-dione

IUPAC name

1-(4-{4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl}-3-nitrophenyl)-3-methylpyrrolidine-25-dione

SMILES

CC(CC(N1c(cc2)cc([N+]([O-])=O)c2N(CC2)CCC2(c(cc2)cc(C(F)(F)F)c2Cl)O)=O)C1=O

InChI

InChI=1S/C23H21ClF3N3O5/c1-13-10-20(31)29(21(13)32)15-3-5-18(19(12-15)30(34)35)28-8-6-22(33,7-9-28)14-2-4-17(24)16(11-14)23(25,26)27/h2-5,11-13,33H,6-10H2,1H3/t13-/m1/s1

InChI Key

ATCFDGYQOCKORG-CYBMUJFWSA-N

MDL Number (MFCD)

MFCD15109157

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

511.88

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.582

Distribution Coefficient, logD

3.582

Water Solubility, LogSw

-4.00

Polar Surface Area

80.495

Acid Dissociation Constant (pKa)

15.40

Base Dissociation Constant (pKb)

-0.45

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.10

K807-4500 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

DGK Inhibitors Library (10558 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
Targets:
  • Proteases
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with K807-4500 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K807-4500?
Check Price and Availability of K807-4500, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K807-4500 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K807-4500
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K807-4500
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K807-4500 available by request